*.*.189.185
药智数据企业版
量身打造,体验升级
立即前往
VIP试用申请
登录 注册
当前位置: 首页 > NME和BLA(美国) 反馈纠错 帮助中心
药智数据企业版注册数据库:增设了"联合申报"、"临床试验默认许可日期"等搜索条件,让搜索页面纬度更加全面,还有热点搜索和高级条件组合检索等检索功能 等你来体验!
-
药品名称 批准类型 活性成分 适应症 上市发布公告 临床试验快照 批准日期 申请机构
Adbry Biologics tralokinumab-ldrm To treat moderate-to-severe atopic dermatitis 2021-12-27 LEO PHARMA AS
Leqvio NME inclisiran To treat heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease as an add-on therapy 2021-12-22 NOVARTIS
Vyvgart Biologics efgartigimod alfa-fcab To treat generalized myasthenia gravis Press Release 2021-12-17 ARGENX BV
Tezspire Biologics tezepelumab-ekko To treat severe asthma as an add-on maintenance therapy 2021-12-17 ASTRAZENECA AB
Cytalux pafolacianine To help identify ovarian cancer lesions Press Release 2021-11-29
Livtencity NME maribavir To treat post-transplant cytomegalovirus (CMV) infection/disease that does not respond (with or without genetic mutations that cause resistance) to available antiviral treatment for CMV Press Release 2021-11-23 TAKEDA PHARMS USA
Voxzogo NME vosoritide To improve growth in children five years of age and older with achondroplasia and open epiphyses Press Release 2021-11-19 BIOMARIN PHARM
Besremi ropeginterferon alfa-2b-njft To treat polycythemia vera, a blood disease that causes the overproduction of red blood cells Press Release 2021-11-12
Scemblix asciminib To treat Philadelphia chromosome-positive chronic myeloid leukemia with disease that meets certain criteria 2021-10-29
Tavneos NME avacopan To treat severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (granulomatosis with polyangiitis and microscopic polyangiitis) in combination with standard therapy, including gl 2021-10-07 CHEMOCENTRYX
Livmarli NME maralixibat To treat cholestatic pruritus associated with Alagille syndrome 2021-09-29 MIRUM
Qulipta NME atogepant To prevent episodic migraines 2021-09-28 ABBVIE INC
Tivdak Biologics tisotumab vedotin-tftv To treat recurrent or metastatic cervical cancer with disease progression on or after chemotherapy 2021-09-20 SEAGEN
Exkivity mobocertinib To treat locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations 2021-09-15
Skytrofa Biologics lonapegsomatropin-tcgd To treat short stature due to inadequate secretion of endogenous growth hormone 2021-08-25 ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S
Korsuva NME difelikefalin To treat moderate-to-severe pruritus associated with chronic kidney disease in certain populations 2021-08-23 CARA THERAPEUTICS INC
Welireg NME belzutifan To treat von Hippel-Lindau disease under certain conditions 2021-08-13 MERCK SHARP DOHME
Nexviazyme Biologics avalglucosidase alfa-ngpt To treat late-onset Pompe disease Press Release 2021-08-06 GENZYME CORP
Saphnelo anifrolumab-fnia To treat moderate-to severe systemic lupus erythematousus along with standard therapy 2021-07-30
Bylvay NME odevixibat To treat pruritus 2021-07-20 ALBIREO PHARMA INC